These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 18312833

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Optimization of the radiolabelling method for improved in vitro and in vivo stability of 90Y-albumin microspheres.
    Aleksandar V, Drina J, Magdalena R, Zorana M, Marija M, Dragana S, Sanja VĐ.
    Appl Radiat Isot; 2020 Feb; 156():108984. PubMed ID: 31760344
    [Abstract] [Full Text] [Related]

  • 4. Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives.
    Béhé M, Becker W, Gotthardt M, Angerstein C, Behr TM.
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1140-6. PubMed ID: 12768330
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Positron-emitting resin microspheres as surrogates of 90Y SIR-Spheres: a radiolabeling and stability study.
    Avila-Rodriguez MA, Selwyn RG, Hampel JA, Thomadsen BR, Dejesus OT, Converse AK, Nickles RJ.
    Nucl Med Biol; 2007 Jul; 34(5):585-90. PubMed ID: 17591559
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preparation and imaging of rhenium-188 labeled human serum albumin microsphere in orthotopic hepatoma rats.
    Ni HC, Yu CY, Chen SJ, Chen LC, Lin CH, Lee WC, Chuang CH, Ho CL, Chang CH, Lee TW.
    Appl Radiat Isot; 2015 May; 99():117-21. PubMed ID: 25748057
    [Abstract] [Full Text] [Related]

  • 9. Disposition of radioactivity after injection of liver-targeted proteins labeled with 111In or 125I. Effect of labeling on distribution and excretion of radioactivity in rats.
    Staud F, Nishikawa M, Morimoto K, Takakura Y, Hashida M.
    J Pharm Sci; 1999 Jun; 88(6):577-85. PubMed ID: 10350492
    [Abstract] [Full Text] [Related]

  • 10. Yttrium-90-labeled human macroaggregated albumin for internal radiotherapy: combined use with DTPA.
    Watanabe N, Oriuchi N, Endo K, Inoue T, Tanada S, Murata H, Sasaki Y.
    Nucl Med Biol; 1999 Oct; 26(7):847-51. PubMed ID: 10628567
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of copper-labeled bifunctional chelate-albumin conjugates for blood pool imaging.
    Anderson CJ, Rocque PA, Weinheimer CJ, Welch MJ.
    Nucl Med Biol; 1993 May; 20(4):461-7. PubMed ID: 8504288
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and biological evaluation of novel macrocyclic ligands with pendent donor groups as potential yttrium chelators for radioimmunotherapy with improved complex formation kinetics.
    Chong HS, Garmestani K, Ma D, Milenic DE, Overstreet T, Brechbiel MW.
    J Med Chem; 2002 Aug 01; 45(16):3458-64. PubMed ID: 12139456
    [Abstract] [Full Text] [Related]

  • 13. Biodistribution and dosimetry of pretargeted monoclonal antibody 2D12.5 and Y-Janus-DOTA in BALB/c mice with KHJJ mouse adenocarcinoma.
    Lubic SP, Goodwin DA, Meares CF, Song C, Osen M, Hays M.
    J Nucl Med; 2001 Apr 01; 42(4):670-8. PubMed ID: 11337558
    [Abstract] [Full Text] [Related]

  • 14. Physical parameters and biological stability of yttrium(III) diethylenetriaminepentaacetic acid derivative conjugates.
    McMurry TJ, Pippin CG, Wu C, Deal KA, Brechbiel MW, Mirzadeh S, Gansow OA.
    J Med Chem; 1998 Aug 27; 41(18):3546-9. PubMed ID: 9719608
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the serum stability and in vivo biodistribution of CHX-DTPA and other ligands for yttrium labeling of monoclonal antibodies.
    Camera L, Kinuya S, Garmestani K, Wu C, Brechbiel MW, Pai LH, McMurry TJ, Gansow OA, Pastan I, Paik CH.
    J Nucl Med; 1994 May 27; 35(5):882-9. PubMed ID: 8176477
    [Abstract] [Full Text] [Related]

  • 16. A facile, water-soluble method for modification of proteins with DOTA. Use of elevated temperature and optimized pH to achieve high specific activity and high chelate stability in radiolabeled immunoconjugates.
    Lewis MR, Raubitschek A, Shively JE.
    Bioconjug Chem; 1994 May 27; 5(6):565-76. PubMed ID: 7873659
    [Abstract] [Full Text] [Related]

  • 17. Influence of different chelators on the radiochemical properties of a 68-Gallium labelled bombesin analogue.
    Asti M, Iori M, Capponi PC, Atti G, Rubagotti S, Martin R, Brennauer A, Müller M, Bergmann R, Erba PA, Versari A.
    Nucl Med Biol; 2014 Jan 27; 41(1):24-35. PubMed ID: 24183610
    [Abstract] [Full Text] [Related]

  • 18. Complexation and biodistribution study of 111In and 90Y complexes of bifunctional phosphinic acid analogs of H4dota.
    Försterová M, Petrík M, Láznicková A, Láznícek M, Hermann P, Lukes I, Melichar F.
    Appl Radiat Isot; 2009 Jan 27; 67(1):21-9. PubMed ID: 18951809
    [Abstract] [Full Text] [Related]

  • 19. Development of [(90)Y]DOTA-conjugated bisphosphonate for treatment of painful bone metastases.
    Ogawa K, Kawashima H, Shiba K, Washiyama K, Yoshimoto M, Kiyono Y, Ueda M, Mori H, Saji H.
    Nucl Med Biol; 2009 Feb 27; 36(2):129-35. PubMed ID: 19217524
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?
    Storch D, Béhé M, Walter MA, Chen J, Powell P, Mikolajczak R, Mäcke HR.
    J Nucl Med; 2005 Sep 27; 46(9):1561-9. PubMed ID: 16157541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.